Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 08:30 ET | Source: Royalty Pharma plc

Royalty Pharma Announces Dividend Increase

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A...
January 09, 2026 08:30 ET | Source: Clene Inc.

Clene Announces Registered Direct Offering of Over $28 Million

Oversubscribed registered direct offering priced above market to new, existing and insider investors, including Boxer Capital Management, Coastlands Capital, and Vivo CapitalInitial financing tranche...
January 09, 2026 08:30 ET | Source: NANO Nuclear Energy Inc.

NANO Nuclear Energy Announces Dismissal of Federal Securities Lawsuit

Dismissal of Federal Securities Class Action Lawsuit Follows Dismissal of Related Shareholder Derivative Lawsuit New York, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:...
January 09, 2026 08:30 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”

-White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies- -Need for swift action by policymakers to...
January 09, 2026 08:30 ET | Source: CorMedix, Inc.

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
January 09, 2026 08:30 ET | Source: Tenaya Therapeutics, Inc.

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC3-Associated HCM Expects to...
January 09, 2026 08:30 ET | Source: CG Oncology Inc.

CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC

- PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial...
January 09, 2026 08:30 ET | Source: Perma-Fix Environmental Services, Inc

Perma-Fix Environmental Services Receives Expanded Permit for Richland Facility, Approximately Tripling Liquid Mixed Waste Processing Capacity

ATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced that it has received a final Dangerous Mixed Waste Permit Renewal for...
January 09, 2026 08:30 ET | Source: Nutanix, Inc.

Nutanix to Present at Upcoming Investor Conference

Nutanix announced that its management will present at the 28th Annual Needham Growth Conference on Friday, January 16, at 8:00 AM PT / 11:00 AM ET.
January 09, 2026 08:30 ET | Source: SEALSQ

SEALSQ and Kaynes SemiCon Reach Final Agreement to Develop a Sovereign Indian Post-Quantum Semiconductor Joint Venture in Alignment with MeitY

Geneva, Switzerland, Jan. 09, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum...